Irvine, California – May 12, 2015. Harbor MedTech, Inc., a fully integrated and diversified tissue regeneration company, announced today that it has been awarded Federal Supply Schedule (“FSS”) contract V797D-50393 effective May 1, 2015 by the Veterans Health Administration. This five year contract approves Architect to be added to the federal government’s GSA system and, specifically, for Architect to be used within the Department of Veteran Affairs healthcare system.

The Veterans Health Administration is the largest integrated health care system in the United States, consisting of 150 medical centers, nearly 1,400 community-based outpatient clinics, community living centers, Vet centers, and Domiciliaries. Together these health care facilities provide comprehensive care to more than 8.3 million Veterans each year.

Architect is a unique extracellular collagen matrix (“ECM”) cleared by the FDA for use as a skin substitute to help manage the treatment of partial or full thickness skin wounds, including diabetic ulcers, venous ulcers, pressure ulcers/sores, trauma and surgical wounds. ECMs are used as “skin substitutes” because of their important tissue regeneration properties. Unfortunately, ECMs are susceptible to rapid degradation in serious or chronic skin wounds. Engineered from Harbor’s patented BriDGE®, Architect is the only stabilized ECM that requires only one application to the wound.

“We are extremely pleased that Architect is now available for treating Medicare patients in outpatient clinics and ambulatory care facilities,” said Jerry Mezger, President and CEO of Harbor. “Not only has Architect proven to be one of the most effective skin substitutes, it is also the most cost effective skin substitute treatment. Cost containment has become a very high priority in today’s healthcare system.”

For more information about Harbor MedTech and Architect, please contact Customer Support:

Telephone: 949.679.4800 x200
Facsimile: 949.679.1086

Architect® and BriDGE® are registered trademarks of Harbor MedTech, Inc.